Antibiotics (HS 2941); Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006) (HS 3003); Medicaments consisting of mixed or unmixed
products for therapeutic or prophylactic uses, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. goods of heading 3002, 3005 or 3006) (HS 3004); Wadding, gauze, bandages and the like, e.g. dressings, adhesive
plasters, poultices, impregnated or covered with pharmaceutical substances or put up for retail sale for medical, surgical, dental or veterinary purposes (HS 3005); Pharmaceutical preparations and products of subheadings 3006.10.10 to 3006.60.90 (HS 3006)

Rectification of the Resolution – RDC number 471, 23 February 2021

The Resolution – RDC number 471, 23 February 2021 – previously notified through G/TBT/N/BRA/1143 – which establishes criteria for prescription, exemption, control, packaging, and labelling of medicines based on substances categorized as antimicrobial for use under prescription, isolated or associated, was rectified.